Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes

ISSN： 0939-5555

Source： Annals of Hematology, Vol.87, Iss.5, 2008-05, pp. : 345-352

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group

By Götze Katharina Platzbecker Uwe Giagounidis Aristoteles Haase Detlef Lübbert Michael Aul Carlo Ganser Arnold Germing Ulrich Hofmann Wolf-Karsten

Annals of Hematology, Vol. 89, Iss. 9, 2010-09 ,pp. : 841-850

Springer Publishing Company

Access to resources Recommend Favorite

Review of therapeutic options and the management of patients with myelodysplastic syndromes

By Özcan Mehmet A Ilhan Osman Ozcebe Osman I Nalcaci Meliha Gülbas Zafer

Expert Review of Hematology, Vol. 6, Iss. 2, 2013-04 ,pp. : 165-189

Informa Healthcare

Access to resources Recommend Favorite

Iron overload and myelodysplastic syndromes.

By Rose C. Cambier N. Mahieu M. Ernst O. Fenaux P.

Transfusion Clinique et Biologique, Vol. 8, Iss. 5, 2001-10 ,pp. : 422-432

Elsevier

Access to resources Recommend Favorite

Caspases and apoptosis in myelodysplastic syndromes

By Mundle S.D. Shetty V.T. Raza A.

Experimental Hematology, Vol. 28, Iss. 12, 2000-12 ,pp. : 1310-1311

Elsevier

Access to resources Recommend Favorite

Cytogenetic features in myelodysplastic syndromes

By Haase Detlef

Annals of Hematology, Vol. 87, Iss. 7, 2008-07 ,pp. : 515-526

Springer Publishing Company

Access to resources Recommend Favorite